Sort
15,440 grants matching “organoids”
Engineering of human intestinal organoids containing immune cells
$353,471Christiane Wobus · University Of Michigan At Ann Arbor · U19 · FY2019 · AI
Epigenetically Engineered Mouse Model for Lung Cancer Therapy
$353,455Lanlan Shen · Baylor College Of Medicine · R01 · FY2023 · CA
Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue
$353,419Pei Wang · University Of Texas Hlth Science Center · R01 · FY2021 · CA
Lipid Metabolism Switch Triggers Invasive and Chemoresistant Epithelial Ovarian Cancer Phenotype
$353,224Michelle R Dawson · Brown University · R01 · FY2022 · CA
Role of Sox2 in stomach development, regeneration and cancer
$353,155Konrad Hochedlinger · Massachusetts General Hospital · R01 · FY2012 · DK
Defining Mechanisms of Transformation Driven By the Zinc Finger Transcription Factor PLAGL2 in the Intestinal Epithelium
$353,076Deborah C. Rubin · Washington University · R01 · FY2023 · CA
Defining Mechanisms of Transformation Driven By the Zinc Finger Transcription Factor PLAGL2 in the Intestinal Epithelium
$353,076Deborah C. Rubin · Washington University · R01 · FY2022 · CA
A Human Organoid Model of Polycystic Kidney Disease
$353,000Benjamin Solomon Freedman · University Of Washington · R01 · FY2022 · DK
A Human Organoid Model of Polycystic Kidney Disease
$353,000Benjamin Solomon Freedman · University Of Washington · R01 · FY2021 · DK
A Human Organoid Model of Polycystic Kidney Disease
$353,000Benjamin Solomon Freedman · University Of Washington · R01 · FY2020 · DK
A Human Organoid Model of Polycystic Kidney Disease
$353,000Benjamin Solomon Freedman · University Of Washington · R01 · FY2019 · DK
The Supramolecular Architecture of the Postsynaptic Density
$352,953Richard J Weinberg · Univ Of North Carolina Chapel Hill · R01 · FY2017 · NS
Human Airway Biomimetics for RSV and Other Respiratory Viruses
$352,938Pedro A Piedra · Baylor College Of Medicine · U19 · FY2021 · AI
Heterogeneous Loss of GDF11 Tumor Suppression in Triple-negative Breast Cancer
$352,925Kevin A Janes · University Of Virginia · R01 · FY2022 · CA
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
$352,912Veronica Rodriguez-Bravo · Mayo Clinic Rochester · R01 · FY2022 · CA
15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid
$352,859Imad Shureiqi · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer
$352,810Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Mechanisms coupling DEK to oncogenesis
$352,801Lisa M. Privette Vinnedge · Cincinnati Childrens Hosp Med Ctr · R37 · FY2019 · CA
ATR inhibitor-mediated reversal of PARP inhibitor resistance in high-grade serous ovarian cancer (HGSOS)
$352,737Geoffrey I Shapiro · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Role of WNT-EGFR crosstalk by EVs and exomeres in normal colon and colon cancer
$352,736Robert J Coffey · Vanderbilt University · P01 · FY2021 · CA
Project 3: Targeting epigenetic regulators in cancer
$352,717Jacqueline A. Lees · Massachusetts Institute Of Technology · P01 · FY2017 · CA
Project 3: Targeting epigenetic regulators in cancer
$352,717Jacqueline A. Lees · Massachusetts Institute Of Technology · P01 · FY2021 · CA
Project 3: Targeting epigenetic regulators in cancer
$352,717Jacqueline A. Lees · Massachusetts Institute Of Technology · P01 · FY2020 · CA
Mechanisms for GH action on epithelial cells
$352,704Shlomo Melmed · Cedars-Sinai Medical Center · R01 · FY2024 · DK
Role of Sox2 in stomach development, regeneration and cancer
$352,698Konrad Hochedlinger · Massachusetts General Hospital · R01 · FY2015 · DK